XML 58 R41.htm IDEA: XBRL DOCUMENT v3.24.3
Investment in Kronos Worldwide, Inc. - Additional Information (Detail)
$ / shares in Units, shares in Millions, $ in Millions
3 Months Ended
Jul. 16, 2024
USD ($)
T
Sep. 30, 2024
USD ($)
$ / shares
shares
Dec. 31, 2023
USD ($)
$ / shares
shares
Kronos | Lousiana Pigment Company      
Schedule Of Equity Method Investments [Line Items]      
Percentage of voting interests acquired 50.00%    
Equity interest in acquiree percentage 50.00%    
Additional production volume acquired in metric tons | T 78,000    
Payments to acquire businesses gross $ 185.0    
Working capital adjustment 11.0    
Business combination contingent consideration liability $ 15.0    
Business combination contingent consideration earn-out period 2 years    
Estimated fair value of the earn-out $ 4.2    
Proceeds from lines of credit 132.1    
Non-cash gain before tax associated with remeasurement   $ 64.5  
Non-cash gain, net of income tax expense   $ 50.9  
Kronos | Lousiana Pigment Company | Aggregate EBITDA is 650 Million      
Schedule Of Equity Method Investments [Line Items]      
Business combination contingent consideration liability 5.0    
Expected aggregate EBITDA achieved for earn out period 650.0    
Kronos | Lousiana Pigment Company | Aggregate EBITDA is 730 Million      
Schedule Of Equity Method Investments [Line Items]      
Business combination contingent consideration liability 15.0    
Expected aggregate EBITDA achieved for earn out period 730.0    
Kronos | Lousiana Pigment Company | Aggregate EBITDA is between 650 Million and 730 Million      
Schedule Of Equity Method Investments [Line Items]      
Business combination contingent consideration liability 10.0    
Kronos | Lousiana Pigment Company | Maximum | Aggregate EBITDA is between 650 Million and 730 Million      
Schedule Of Equity Method Investments [Line Items]      
Expected aggregate EBITDA achieved for earn out period 730.0    
Kronos | Lousiana Pigment Company | Minimum | Aggregate EBITDA is between 650 Million and 730 Million      
Schedule Of Equity Method Investments [Line Items]      
Expected aggregate EBITDA achieved for earn out period $ 650.0    
Kronos      
Schedule Of Equity Method Investments [Line Items]      
Number of shares owned | shares   35.2 35.2
Aggregate market value   $ 438.5 $ 350.1
Quoted market price per share | $ / shares   $ 12.45 $ 9.94